Fact CheckerSign in

NCT06523660Completed

Improving Executive Function in Korean Children With Autism

A Randomized, Control Trial of Executive Function Training for Korean Kindergartners With Autism Spectrum Disorder

Source: ClinicalTrials.gov · Last updated 23 Sept 2026

Brief summary (registry, in English)

The purpose of this randomized controlled study is to evaluate the acceptability, feasibility, and preliminary efficacy of an executive function (EF) training intervention for 5- to 7-year-old autistic children in South Korea. This study will have three aims: (1) to assess the acceptability and feasibility of the EF intervention with children with ASD; (2) to examine clinically important effects of the intervention using multimodal methods combining lab-based behavioral tasks and novel electrophysiological measures; and (3) to determine whether the effects are generalized to everyday EF skills in real-world settings using parent-ratings.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
17 Jul 2024
Start date
11 Sept 2024
Primary completion date
15 Mar 2026
Lead sponsor
Korea University
Diseases
Autism
NCT number
NCT06523660

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 11 Sept 2024 to the primary completion date, 15 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of medical disorders or injuries with implications for the central nervous system or that require medications that alter EEG processes such as anticonvulsants
  • Presence of significant sensory or motor impairment

Other

  • NVIQ below 85
  • Presence of major physical anomalies

Who the study is looking for

  • Previous medical diagnosis of ASD, confirmed by Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)
  • Non-verbal IQ (NVIQ) equal to or above 85
  • Verbal children (with flexible phrases or complex sentences)

Age in the registry: 5 years to 7 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Korea University
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.